Grifols, S.A.

GRFS Stock Healthcare Drug Manufacturers - General
$7.73
+0.01 (+0.13%)
Price as of Sep 01, 2026 market close

Performance

1 Month
-1.7%
3 Months
+2.6%
YTD
-16.2%
1 Year
-21.4%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
32.1%
Largest decline max drawdown, since Aug 2025
-33.1%
Risk-adjusted return Sharpe ratio, 1-year
-0.59

Own GRFS?

See how GRFS contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.